George Sellers
Stock Analyst at Stephens & Co.
(1.05)
# 3,836
Out of 5,050 analysts
43
Total ratings
27.27%
Success rate
-7.09%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $68 | $65.00 | +4.62% | 7 | Aug 7, 2024 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $109.40 | +165.08% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $38.94 | +48.95% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $119.17 | +49.37% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $9.85 | +143.65% | 6 | May 29, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $28.06 | +156.59% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $3.87 | +29.20% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $4.47 | +459.91% | 4 | Sep 12, 2023 | |
| STAA STAAR Surgical Company | Reiterates: Overweight | $57 | $26.55 | +114.69% | 6 | Aug 14, 2023 | |
| GKOS Glaukos | Reiterates: Overweight | $71 | $83.86 | -15.34% | 4 | May 8, 2023 |
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $65.00
Upside: +4.62%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $109.40
Upside: +165.08%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $38.94
Upside: +48.95%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $119.17
Upside: +49.37%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $9.85
Upside: +143.65%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $28.06
Upside: +156.59%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $3.87
Upside: +29.20%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $4.47
Upside: +459.91%
STAAR Surgical Company
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $26.55
Upside: +114.69%
Glaukos
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $83.86
Upside: -15.34%